Trial record 1 of 1 for:    squalamine eye drops amd
Previous Study | Return to List | Next Study

Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)

This study is currently recruiting participants.
Verified January 2013 by Ohr Pharmaceutical Inc.
Sponsor:
Information provided by (Responsible Party):
Ohr Pharmaceutical Inc.
ClinicalTrials.gov Identifier:
NCT01678963
First received: August 27, 2012
Last updated: January 21, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)